Instalab

BMD T-Score (Left Total Hip)

The single best predictor of hip fracture risk, years before a bone might break.

Should you take a BMD T-Score (Left Total Hip) test?

This test is most useful if any of these apply to you.

Going Through or Past Menopause
Bone loss accelerates once estrogen drops. This scan tells you whether your hip bones are quietly thinning so you can act before a first fracture.
Taking Long-Term Steroids
Even short courses of prednisone measurably weaken bone. If you have been on steroids for months, you need to know your baseline now.
Already Had a Fragility Fracture
Breaking a wrist, hip, or vertebra from a minor fall means your bones are at high risk. A scan helps target treatment to prevent the next break.
Healthy but Want to Stay Ahead
Get a baseline in your 40s or 50s so you have decades of trend data, not a single number after something has already gone wrong.

About BMD T-Score (Left Total Hip)

Hip fractures are not just a broken bone. They carry the highest risk of disability, hospital readmission, and death of any common bone break, and most happen in people who had no idea their bones were thinning.

Your left hip T-score (a number from a low-dose hip scan called DXA, short for dual-energy X-ray absorptiometry) is the most direct read on whether your hip bone can withstand a fall. Each one-point drop in this number roughly doubles your hip fracture risk.

What Your T-Score Actually Means

The T-score is not a hormone or a protein. It is a comparison. Your hip bone density is measured in grams per square centimeter, then compared to the peak bone density of healthy young adults. The score tells you how many standard deviations (a statistical measure of how far you sit from average) your bones fall above or below that young-adult peak.

The World Health Organization categories are simple. A score of -1.0 or higher is normal. A score between -1.0 and -2.5 is low bone mass, often called osteopenia. A score of -2.5 or lower meets the diagnostic threshold for osteoporosis. These same cutpoints apply to men and women, because at any given hip density, the average hip fracture risk is similar between sexes.

Why Hip Density Predicts Future Fractures

Among bone scan sites, the hip is the most reliable predictor of hip fracture risk, the fracture that matters most for survival and independence. The relationship is steep and consistent across populations.

  • Per-point risk: In a real-world cohort of about 15,000 women, each one-unit higher total hip T-score was strongly tied to fewer clinical, nonvertebral, vertebral, and hip fractures over 24 months.
  • Asian and White women: Each one-unit decline in femoral neck T-score at least doubled hip fracture risk across ethnicities in a study of nearly 274,000 women.
  • Type 2 diabetes: Femoral neck T-score predicted hip, non-spine, and major osteoporotic fractures similarly in people with and without diabetes, with risk roughly doubling per one-unit drop.
  • Long-term tracking: A single hip T-score predicted hip fracture risk over 25 years in postmenopausal women, with the oldest age groups carrying the highest absolute long-term risk.

The risk reduction from a higher hip T-score is not linear. It plateaus around a score of -1.5 to -2.0, which is why many specialists treat that range as a practical target for therapy rather than chasing a normal score in someone with severe bone loss.

Why Both Hips Matter (and What a Left-Only Result Misses)

Left and right hips are not interchangeable. In 3,012 women aged 50 and older, large left-right differences in hip bone density were common, with 47% at total hip, 31% at femoral neck, and 56% at the trochanter exceeding measurement error.

Scanning only one hip misses real cases of osteoporosis. About 1% of women with normal spines were osteoporotic only in the left hip, and another 1% only in the right. In stroke survivors, the side with weakness had significantly lower hip T-scores than the unaffected side, with 17% showing meaningful difference between hips. If your scan was done on the left hip only, your true bone status may be slightly better or worse than the number suggests.

Reference Ranges

These ranges come from the World Health Organization criteria used across major guidelines and apply to postmenopausal women and men aged 50 and older. Younger adults are interpreted differently (Z-scores rather than T-scores). Your lab's reference adult database can shift values slightly; newer reference data tend to classify more people as having low bone mass or osteoporosis.

CategoryT-Score RangeWhat It Suggests
Normal-1.0 or higherBone density within one standard deviation of a healthy young adult; low near-term fracture risk
Low bone mass (osteopenia)Between -1.0 and -2.5Thinning bone; fracture risk roughly doubles with each one-point drop
Osteoporosis-2.5 or lowerDiagnostic threshold; meets criteria for pharmacologic treatment per major guidelines
Practical treatment targetAround -1.5 to -2.0Risk reduction plateaus here in observational studies of treated patients

Source: WHO diagnostic criteria; treatment-target observations from Banefelt 2021 and Ferrari 2019. For meaningful tracking, compare your results within the same lab and machine over time.

Beyond Fractures: Other Outcomes Tied to Low Hip Density

A low hip T-score is not just about the bone itself. It is associated with broader markers of frailty and slower recovery.

  • Surgical outcomes: Adults with hip osteoporosis have more complications and revisions after total hip and knee replacement.
  • Cardiovascular signals: A meta-analysis of prospective cohort studies linked lower bone density to higher all-cause and cardiovascular mortality, though not stroke mortality.
  • Hidden in plain sight: In one large series of patients undergoing hip replacement for arthritis, osteoporosis was both highly prevalent and largely undiagnosed beforehand.

When Results Can Be Misleading

  • Single-hip scanning: Up to half of measurements differ between left and right hips by more than the test's measurement error. If only your left hip was scanned, you may be missing osteoporosis present on the right.
  • Hip hardware or arthritis: Implants, severe arthritis, or vascular calcifications in the scan field can artificially raise the apparent bone density. The number looks better than the bone really is.
  • Lab and machine differences: Different DXA machines and reference databases can shift your T-score. Always compare scans done on the same machine when possible, and ask your lab whether they updated their reference dataset between scans.
  • Recent fracture or surgery: Bone remodeling after a recent hip fracture or arthroplasty distorts the reading on that side.

Tracking Your Trend

A single T-score is a snapshot. The more useful question is which direction your bones are moving. Bone density changes slowly, so the value of tracking is in catching a downward trend before you cross into the osteoporotic range, and in confirming that a treatment or lifestyle change is actually working.

Get a baseline scan, then repeat in 1 to 2 years if you are starting therapy or making major lifestyle changes. Once your score is stable, every 2 years is reasonable for most adults. People on long-term steroids, with aromatase inhibitors, or with newly diagnosed conditions that affect bone should test more often. The key is using the same lab and machine each time, since left and right hips and different scanners can produce different numbers for the same person.

What to Do If Your T-Score Is Low

If your left hip T-score is in osteopenia range (-1.0 to -2.5), the next step is a FRAX assessment (Fracture Risk Assessment Tool, a calculator combining your T-score with age, weight, and clinical risk factors) to estimate your 10-year fracture risk. Treatment is typically recommended when major osteoporotic fracture risk exceeds 20% or hip fracture risk exceeds 3%, even at osteopenia T-scores.

If your score is at or below -2.5, that meets the diagnostic threshold for osteoporosis and warrants treatment regardless of FRAX. Companion tests to order alongside a low T-score include vitamin D, calcium, kidney function, parathyroid hormone, and bone turnover markers like CTX (a marker of bone breakdown). These help identify reversible secondary causes of bone loss. A bone-specialized endocrinologist or rheumatologist is the right specialist when your scan, FRAX score, or workup raises questions beyond standard care.

What Moves This Biomarker

Evidence-backed interventions that affect your BMD T-Score (Left Total Hip) level

Increase
Denosumab injection (a twice-yearly biologic that blocks bone breakdown)
Higher total hip T-scores during denosumab treatment translate directly into fewer fractures. In a 10-year analysis of 1,343 postmenopausal women, every one-unit increase in total hip T-score was tied to lower nonvertebral fracture risk, with the protective effect leveling off around a T-score of -2.0 to -1.5. Doctors often use this range as the treatment target on therapy.
MedicationStrong Evidence
Increase
Bisphosphonate therapy (oral or intravenous bone-preserving drugs such as alendronate or zoledronate)
Bisphosphonates raise total hip bone density and cut fracture risk in a dose-response manner. In a real-world analysis of about 15,000 women, each one-unit higher total hip T-score during bisphosphonate treatment was tied to fewer clinical, nonvertebral, vertebral, and hip fractures over 24 months. They are first-line for most patients with osteoporosis under major guidelines.
MedicationStrong Evidence
Decrease
Long-term oral corticosteroid therapy (such as prednisone for asthma, autoimmune disease, or transplant)
Systemic steroids cause real bone loss, not just a number on a chart. Even 2 to 6 weeks of treatment in children measurably decreased bone density across sites, and the loss persisted at 3 months after stopping. In adults, glucocorticoid-induced osteoporosis is a recognized clinical entity, and guidelines recommend DXA monitoring and protective treatment for anyone on chronic steroids.
MedicationStrong Evidence
Increase
Multicomponent exercise program (combining resistance, balance, and weight-bearing aerobic work)
A 4-month structured multicomponent exercise program improved left total hip T-scores in older women with osteopenia, while spine T-scores changed little. Translation: weight-bearing movement that loads the hip joint is the right kind of exercise for hip bone density, and you can see measurable change within months.
ExerciseModerate Evidence
Decrease
TSH suppression therapy after thyroid cancer (high-dose levothyroxine to keep thyroid-stimulating hormone low)
In a meta-analysis of differentiated thyroid cancer survivors, TSH suppression was tied to lower total hip bone density in postmenopausal women, with a trend toward reduced hip T-scores. This is real, treatment-driven bone loss, not a measurement artifact. If you are on suppressive thyroid therapy after thyroid cancer, your bones need active monitoring.
MedicationModerate Evidence
Decrease
Chronic proton pump inhibitor use in older men (acid-blocking drugs like omeprazole or pantoprazole)
Chronic PPI use in older men was tied to lower total hip and femoral neck T-scores in a NHANES analysis of nearly 7,500 adults, with prolonged use in men over 70 also linked to reduced bone density. Evidence in women is less consistent, and one large registry study found no effect after full adjustment for abdominal obesity. If you are a man on chronic PPIs, consider whether the indication still applies.
MedicationModest Evidence

Frequently Asked Questions

References

26 studies
  1. Hamdy R, Kiebzak G, Seier E, Watts NOsteoporosis International2006
  2. Yoo SD, Kim TW, Oh BM, Lee SA, Kim C, Chung H, Son J, Lee JY, Lee H, Lee HYAnnals of Rehabilitation Medicine2024
  3. Delsmann MM, Strahl a, Mühlenfeld M, Jandl N, Beil F, Ries C, Rolvien TOsteoporosis International2021
  4. Ferrari S, Libanati C, Lin C, Brown J, Cosman F, Czerwiński E, De Gregόrio LH, Malouf-sierra J, Reginster J, Wang a, Wagman R, Lewiecki EJournal of Bone and Mineral Research2019
  5. Banefelt J, Timoshanko J, Söreskog E, Ortsäter G, Moayyeri a, ÅKesson K, Spångeus a, Libanati CJournal of Bone and Mineral Research2021